Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 6-K Current report (foreign)
- 99.1 Inflarx N.V. Unaudited Condensed Consolidated Financial Statements As of and for the Three and Six Months Ended June 30, 2024
- 99.2 Inflarx N.V. Management's Discussion and Analysis of Financial Condition and Results of Operations
- 99.3 Inflarx N.V. Press Release Dated August 8, 2024
- Download Excel data file
- View Excel data file
IFRX similar filings
- 20 Dec 24 InflaRx Announces First Patient Dosed in Phase 2a Study for Oral C5aR Inhibitor INF904
- 15 Nov 24 Current report (foreign)
- 8 Nov 24 Current report (foreign)
- 8 Aug 24 Report of Foreign Private Issuer
- 28 Jun 24 Leerink Partners LLC
- 24 Jun 24 Current report (foreign)
- 5 Jun 24 InflaRx Hosts R&D Event Highlighting the Promise of INF904
Filing view
External links